SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination. Behrens GM, Cossmann A, Stankov MV, Nehlmeier I, et al. Lancet 2021 Aug 17. pii: S0140-6736(21)01891.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Behrens GM, Cossmann A, Stankov MV, Nehlmeier I, et al. SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination. Lancet 2021 Aug 17. pii: S0140-6736(21)01891.
PMID: 34416198